1. Home
  2. IRWD vs PGY Comparison

IRWD vs PGY Comparison

Compare IRWD & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • PGY
  • Stock Information
  • Founded
  • IRWD 1998
  • PGY 2016
  • Country
  • IRWD United States
  • PGY United States
  • Employees
  • IRWD N/A
  • PGY N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • PGY Finance: Consumer Services
  • Sector
  • IRWD Health Care
  • PGY Finance
  • Exchange
  • IRWD Nasdaq
  • PGY Nasdaq
  • Market Cap
  • IRWD 716.9M
  • PGY 747.6M
  • IPO Year
  • IRWD 2010
  • PGY N/A
  • Fundamental
  • Price
  • IRWD $4.44
  • PGY $11.35
  • Analyst Decision
  • IRWD Buy
  • PGY Strong Buy
  • Analyst Count
  • IRWD 4
  • PGY 9
  • Target Price
  • IRWD $12.00
  • PGY $22.89
  • AVG Volume (30 Days)
  • IRWD 1.5M
  • PGY 2.4M
  • Earning Date
  • IRWD 11-07-2024
  • PGY 10-31-2024
  • Dividend Yield
  • IRWD N/A
  • PGY N/A
  • EPS Growth
  • IRWD N/A
  • PGY N/A
  • EPS
  • IRWD 0.06
  • PGY N/A
  • Revenue
  • IRWD $400,565,000.00
  • PGY $925,421,000.00
  • Revenue This Year
  • IRWD N/A
  • PGY $26.59
  • Revenue Next Year
  • IRWD $2.80
  • PGY $14.40
  • P/E Ratio
  • IRWD $78.45
  • PGY N/A
  • Revenue Growth
  • IRWD N/A
  • PGY 18.78
  • 52 Week Low
  • IRWD $3.79
  • PGY $8.56
  • 52 Week High
  • IRWD $15.70
  • PGY $20.51
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 52.71
  • PGY 51.09
  • Support Level
  • IRWD $4.06
  • PGY $10.64
  • Resistance Level
  • IRWD $4.39
  • PGY $11.87
  • Average True Range (ATR)
  • IRWD 0.24
  • PGY 0.63
  • MACD
  • IRWD 0.07
  • PGY 0.22
  • Stochastic Oscillator
  • IRWD 82.35
  • PGY 75.70

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

Share on Social Networks: